In less than eight hours last June, Yale New Haven’s emergency department treated 12 patients who had overdosed on opioids. Three died; nine were saved. With opioids in wide circulation, Dr. Gail D’Onofrio, chief of emergency medicine at the hospital and chair of emergency medicine at Yale School of Medicine, isn’t sure that one-day spike will stand as a record. “To be honest, no, I don’t expect the numbers to get better,” D’Onofrio said. “We’re going to have more treatment options in Connecticut, I think, more safe prescribing — but I don’t know that we’ll see improvements in the numbers of people using.”
D’Onofrio’s concerns are borne out in a recent report by the Agency for Healthcare Research and Quality (AHRQ) that ranks Connecticut the 5th highest among 30 states in the rate of opioid-related emergency department (ED) visits — 254.6 per 100,000 population in 2014, well above national rate of 177.7.
A growing number of women are getting hurt by falling, and they are much more likely to suffer fall-related injuries than men, data show. From 2011 to 2014, 51 women per 1,000 population were hurt in falls, up from 47 per 1,000 from 2005 to 2008, according to recent data from the National Center for Health Statistics and the Centers for Disease Control and Prevention (CDC). Falls were the most common cause of nonfatal injuries to women, the report found, and significantly outpaced injuries from overexertion, the second leading cause of injury that afflicted just 14 per 1,000.
Hormone-related changes associated with menopause are the main reasons women are so prone to falling, especially as they age, said Dr. Karen Sutton, an orthopaedic surgeon, director of Women’s Sports Medicine at Yale New Haven Hospital, and associate professor of orthopaedics and rehabilitation at the Yale School of Medicine. “Their muscles are weaker, their bones are weaker,” she said, since hormone changes lead to reduced bone mass and the onset of osteoporosis in many women.
Women who spend many years working long hours have significantly higher chances of developing heart disease, cancer and other chronic diseases, according to new research. The study found that women who worked more than 60 hours per week were nearly three times more likely to develop heart disease, non-skin cancers, arthritis and diabetes than those who worked less. Researchers at the Center for HOPES at Ohio State University’s College of Public Health and the Center for the Science of Health Care Delivery at Mayo Clinic conducted the research. Even among women who worked fewer than 60 hours per week, the odds of developing the chronic ailments grew as women’s work hours increased, according to the study—a trend that did not hold true for men. Men who worked longer hours had an increased risk only of developing arthritis, and actually had a decreased risk of heart disease when they worked “moderately long hours” of 41 to 50 hours per week.
A growing number of adolescents in Connecticut and nationwide are protecting themselves from human papillovirus (HPV), new data show, but disparities persist in who is getting vaccinated. Statewide and nationally, adolescent girls were vaccinated at much higher rates than boys in 2015. In Connecticut, 55 percent of girls received all three doses of the vaccine, compared to 42 percent of boys, the Centers for Disease Control and Prevention reports. Nationally, 42 percent of girls and 28 percent of boys received all three shots, the CDC data show. Nationally, Hispanic girls (46 percent) and boys (35 percent) received all three doses, compared to African American girls (41 percent) and African American boys (26 percent), and white girls (40 percent) and white boys (25 percent), the CDC reports.
Dozens of Connecticut doctors accepted six-figure payments from drug and medical device manufacturers in 2015 for consulting, speaking, meals and travel, with six of the 10 highest-paid physicians affiliated with academic institutions, new federal data show. The top 10 doctors – less than 0.1 percent of the 11,000 who received payments – took in $3.6 million, or nearly 15 percent of the total $24.9 million paid out. Among them is the dean of the Yale School of Medicine, Dr. Robert Alpern, who received $445,398 in 2015 from two companies – Abbott Laboratories and AbbVie – in consulting fees, meals and travel expenses for serving on the boards of both companies. In 2014, he received $458,194 from the two companies. The Yale medical school began a research partnership with AbbVie in 2013, after the pharmaceutical company spun off from Abbott Laboratories.
A growing number of adults—about 52 million—suffer from arthritis, and data show women are more likely than men to develop it. In 2014, 26.5 percent of women reported having doctor-diagnosed arthritis, compared with 20.5 percent of men, according to new data from the Centers for Disease Control and Prevention behavioral risk survey. Many women don’t realize they are at a higher risk than their male peers, said Dr. Abhijeet Danve, a rheumatologist and faculty member in Yale School of Medicine’s rheumatology division. “Of all the patients with arthritis, almost 60 percent of them are women,” he said. Several factors likely make women more susceptible than men: biological traits, genetics and hormones, Danve said.
In hospitals across Connecticut and nationwide, workarounds to compensate for medication shortages are daily routines for treating patients – and health experts say it’s not about to change any time soon. Some acute-care drugs in short supply nationally are antibiotics, antipsychotics, intravenous saline, and morphine, according to the most recent shortage list from the U.S. Food and Drug Administration. In Connecticut, hospital officials say they are turning to alternative drugs, rationing supplies, or seeking new suppliers to work around the shortages. At St. Francis Hospital and Medical Center in Hartford, Dr. C. Steven Wolf, chief of emergency medicine, said doctors most recently have been dealing with shortages of dextrose, used to treat dehydration and low blood sugar, as well as intravenous saline and other basic medications.
More Connecticut doctors, therapists and psychologists are turning to the practice of mindfulness to help treat depression, anxiety, chronic pain and even addiction. The practice — which cultivates an awareness of the present moment and an acceptance of the feelings and emotions that come with it — has reached the mainstream and is being adopted by new fields. Veterans groups are using mindfulness and yoga as a healing tool. Teachers in some Connecticut elementary schools have incorporated it into their classrooms to help students focus. And universities are offering mindfulness training to help students deal with stress.
Like all pediatricians, Dr. Lori Smith keep tabs on many aspects of her patients’ health, but until recently the Westport-based doctor didn’t always consider whether the children she sees might be going hungry. “It wasn’t something that was necessarily on our radar,” she said. While her practice treats some lower-income patients from nearby Norwalk and Bridgeport, most of the children Smith and her colleagues see come from relatively affluent families. But Smith, who has been a pediatrician for more than 16 years, and her colleagues recently began screening all patients—regardless of their household income—for food insecurity, part of a new effort doctors and advocates hope will help prevent childhood hunger. The American Academy of Pediatrics (AAP) in October recommended that pediatricians screen all patients for hunger at well visits.
Black women with breast cancer fare worse than other women when treated with early chemotherapy, according to new research from the Yale Cancer Center. Typically, black, Hispanic and Asian women are more likely to undergo neoadjuvant chemotherapy, or chemotherapy prior to surgery, than white women because they are more likely to develop advanced-stage breast cancer. But the new study found that black women are less likely to benefit from the treatment. The finding is significant because it proves further research is needed, and could impact how future research and treatment options are pursued for black women, said Brigid Killelea, the study’s first author and associate professor of surgery at Yale School of Medicine. “African American women didn’t respond as well to the chemotherapy when a pathologist looked at the tumors under a microscope after [subsequent] surgery,” she said.